XSTO
ADDV B
Market cap108mUSD
Feb 17, Last price
1.73SEK
Name
ADDvise Group AB (publ)
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
ADDvise Group AB (publ), established in Stockholm, Sweden, in 1989, furnishes specialized equipment to both public and private medical and scientific institutions globally, with operations spanning Sweden, the broader European continent, North America, Africa, and Asia. The company's business is structured into two primary divisions: Lab and Healthcare. The Lab segment is dedicated to the development, production, and distribution of controlled environment solutions and advanced ventilation systems specifically for laboratories. It also supplies precision weighing instruments for scientific, industrial, and retail applications, alongside a comprehensive range of laboratory instruments like centrifuges, water baths, and environmental chambers. This division further provides maintenance services for scales and lab apparatus, product storage solutions, and offers laboratory furniture and general equipment. Conversely, the Healthcare division specializes in the design, production, and commercialization of a wide array of medical devices. This includes surgical operating tables, general healthcare and safety goods, medical technology cables, connectivity solutions, orthopedic implants, specialized stents for foot and ankle procedures, and patient monitoring devices with associated software. This unit also distributes disposable medical supplies, ultrasound imaging systems, radiographic machinery, and specialized examination tables for urological and gynecological practices, in addition to managing an e-pharmacy platform.
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||